Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation
Pavan Bhargava, Kathryn C. Fitzgerald, Peter A. Calabresi, Ellen M. Mowry
Pavan Bhargava, Kathryn C. Fitzgerald, Peter A. Calabresi, Ellen M. Mowry
View: Text | PDF
Clinical Research and Public Health Immunology Neuroscience

Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation

Abstract

BACKGROUND. Our goal was to identify changes in the metabolome in multiple sclerosis (MS) and how vitamin D supplementation alters metabolic profiles in MS patients and healthy controls. METHODS. We applied global untargeted metabolomics to plasma from a cross-sectional cohort of age- and sex-matched MS patients and controls and a second longitudinal cohort of MS patients and healthy controls who received 5,000 IU cholecalciferol daily for 90 days. We applied partial least squares discriminant analysis, weighted correlation network analysis (WGCNA), and pathway analysis to the metabolomics data. Generalized estimating equations models were used to assess change in WGCNA-identified module scores or metabolite pathways with vitamin D supplementation. RESULTS. Utilizing multiple analytical techniques, we identified metabolic alterations in oxidative stress (γ-glutamyl amino acid, glutathione) and xenobiotic metabolism (benzoate, caffeine) in MS patients compared with healthy controls in the first cohort. In the vitamin D supplementation cohort, we identified two sets of metabolites altered differentially between MS patients and healthy controls with vitamin D supplementation. The first included markers of oxidative stress and protein oxidation (P = 0.006), while the second contained lysolipids and fatty acids (P = 0.03). CONCLUSIONS. Using metabolomics, we identified alterations in oxidative stress and xenobiotic metabolism in MS patients and subsequently demonstrated a reduction of oxidative stress markers with vitamin D supplementation in healthy controls but not in MS patients. We demonstrate the utility of metabolomics in identifying aberrant metabolic processes and in monitoring the ability of therapeutic interventions to correct these abnormalities. TRIAL REGISTRATION. ClinicalTrials.gov NCT01667796. FUNDING. This study was supported by NIH grant K23 NS067055, grants from the Race to Erase MS, the National Multiple Sclerosis Society, the American Academy of Neurology, and North American Research Committee on Multiple Sclerosis.

Authors

Pavan Bhargava, Kathryn C. Fitzgerald, Peter A. Calabresi, Ellen M. Mowry

×

Figure 3

Cross-sectional cohort — results of pathway analyses using weighted correlation network analysis.

Options: View larger image (or click on image) Download as PowerPoint
Cross-sectional cohort — results of pathway analyses using weighted corr...
(A) Box plots of eigen-metabolite levels for green module and brown module that significantly differ between multiple sclerosis (MS) cases and healthy controls (HC) (P = 0.05 for both; based on linear models adjusted for age and sex). Bounds of the box itself represent interquartile range (IQR), while the central line within the box represents the median, and minimum and maximum whiskers represent Q1–Q1.5 × IQR (or the absolute maximum, if smaller) and Q3 + 1.5 × IQR (or the absolute minimum, if larger), respectively. (B) Correlations between metabolites belonging to the green and brown modules. Each pie represents one metabolite within the module, where darker or brighter green or brown hues denote more significant results from the individual tests (P values are listed in Table 2) assessing whether a given metabolite significantly differs between MS patients and HCs. The length of each pie is proportional to the number of correlations a given metabolite has with other metabolites in the green or brown module that exceed 0.45. A connecting line is drawn between the metabolite pies if the metabolite-metabolite correlation is at least 0.45. For example, weighted correlation network analysis (WGCNA) classifies the metabolite glutamate into the green module, and the correlation between maleate and glutamate (classified by WGCNA into the brown module) is ≥0.45. As a result, there is a line connecting the glutamate and maleate pies within the circos plot. We observe some potential intermodular correlation between brown and green modules, where green and brown eigen-metabolites are marginally correlated (Pearson’s r = 0.27; P = 0.045). The contents of these modules are listed in Table 3 and Supplemental Table 1. (C) Relation between metabolite module-membership scores and difference in mean for metabolites between MS cases and HCs. The hue of brown or green color denotes the degree of significance for a test of differences between mean metabolite levels between MS patients and HCs (the darker the hue of green or brown denotes the more significantly different a given metabolite is between MS patients and HCs). Metabolite module-membership scores are derived as the correlation between the overall metabolite module eigen-metabolite score and that of the individual metabolite.